About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Merits of Considering Combination Versus Sequential Chemotherapy in Metastatic Breast Cancer

by Rajashri on August 6, 2009 at 9:15 PM
Font : A-A+

 Merits of Considering Combination Versus Sequential Chemotherapy in Metastatic Breast Cancer

A new commentary published online August 5 in the Journal of the National Cancer Institutesays that both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and disease-related factors.

Whether to use several chemotherapy drugs simultaneously or single agents sequentially, one after the other, is a controversial issue. To explore this question, the European School of Oncology Metastatic Breast Cancer Task Force held an open debate on the relative benefits of combination versus sequential therapy at the 6th European Breast Cancer Conference.

Advertisement

In this commentary, Fatima Cardoso, M.D., of the Jules Bordet Institute in Brussels, and colleagues summarize the recommendations of that task force, which includes the use of sequential chemotherapy with a single agent for patients with advanced metastatic breast cancer without rapid progression or life-threatening metastasis, and for those who do not need rapid symptom or disease control.

The authors do not take one side over the other. Instead, they discuss the contributions and caveats of existing data on the two therapies. They do, however, note that because metastatic breast cancer is incurable, quality of life and overall survival should be the endpoints against which any systemic therapy is evaluated.
Advertisement

"Ultimately, the choice between combination and sequential systemic therapy for metastatic breast cancer must involve an open discussion of potential side effects and logistical requirements with patients, taking into consideration the cost and availability of chemotherapeutic agents in local clinical practice settings," the authors write.



Source: Eurekalert
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Pagets disease of the breast Mastitis Cancer and Homeopathy Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Breast Cancer Facts 

Most Popular on Medindia

Iron Intake Calculator Loram (2 mg) (Lorazepam) Find a Hospital Sinopril (2mg) (Lacidipine) The Essence of Yoga Calculate Ideal Weight for Infants Find a Doctor How to Reduce School Bag Weight - Simple Tips Blood Pressure Calculator Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use